Genome Integrity Solutions

https://missionbio.com/genome-integrity-assay-development/ Designed to validate the safety and efficacy of CRISPR and other gene-editing therapies, this solution detects on- and off-target edits, translocations, and chromosomal aneuploidy across thousands of cells without the need for time-consuming clonal outgrowth. By resolving the specific genomic architecture of every cell, it allows researchers to identify rare, potentially dangerous subclones that bulk sequencing misses, serving as a critical quality control standard for characterization and release testing in cell and gene therapy development.